The Supervisory Committee of Mediq, international supplier of medical devices and pharmaceuticals, have re-appointed Marc van Gelder Chief Executive Officer (CEO) as of 1 January 2013.
The General Meeting of Shareholders of Mediq was informed at the annual shareholders meeting on 11 April 2012. Van Gelder is appointed for a period of 4 years. Van Gelder became a member of the Board of Management of Mediq as of 1 January 2005 and was appointed Chief Executive Officer per 1 December 2005. Before joining Mediq, he held positions at McKinsey & Company and Royal Ahold.
To have press releases sent directly to your email address, please subscribe to the email alert service.
Mediq
Hertogswetering 159
3543 AS Utrecht
the Netherlands
T +31 30 282 19 11
F +31 30 289 66 50
Investors
Catrien van Buttingha Wichers
Corporate Communication Director
T +31 30 2821609
M +31 6 5339 3665
catrien.van.buttingha@mediq.com
Media
Ynte Hoekstra, Manager Corporate Communications
T +31 (0)30 282 1061
M +31 (0)6 2219 7204
ynte.hoekstra@mediq.com
Annegees van Linge, PR & Communications Advisor
T +31 (0)30 282 1325
M +31 (0)6 4610 5682
annegees.van.linge@mediq.com
distributed by |